This study aimed to compare the levels of anti-PR3, anti-MPO, and anti-GBM autoantibodies in patients hospitalized with the Omicron variant of COVID-19 against those with the Delta variant, and to examine their correlations with clinical symptoms and laboratory parameters. Here, PRTN3 is linked to COVID-19.